MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
Zhiyu Li(Wuhan University), Shengrong Sun(Wuhan University)
Cited by 32
Related Papers
Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3
|PLoS ONE|2015|68
Knockdown of B7H6 inhibits tumor progression in triple‑negative breast cancer
|Oncology Letters|2018|22
UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA‑MB‑231 cells
|Experimental and Therapeutic Medicine|2018|13
NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer
|Frontiers in Oncology|2021|7
Macrophages in Tumor-Associated Adipose Microenvironment Accelerate Tumor progression
|Research Square|2020|3